Castleman disease and TAFRO syndrome

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Castleman disease (CD) encompasses diverse conditions, including unicentric and multicentric forms, often challenging to diagnose due to rarity and overlapping features.
• TAFRO syndrome, a related disorder, presents with similar lymph node histology to CD but distinct clinical manifestations.
• Current diagnostic challenges necessitate the identification of novel, disease-specific biomarkers for accurate differentiation.

Purpose of the Study:

• To review and delineate the distinct characteristics of Castleman disease and TAFRO syndrome.
• To highlight the diagnostic complexities and the need for improved discriminatory methods.
• To emphasize the importance of identifying novel biomarkers for precise diagnosis.

Main Methods:

• Literature review of Castleman disease and TAFRO syndrome characteristics.
• Comparative analysis of clinical and pathological features.
• Discussion of current diagnostic limitations and biomarker research.

Main Results:

• Castleman disease includes unicentric, multicentric (HHV-8 related and idiopathic), and mimic forms.
• TAFRO syndrome shares histological similarities with CD but exhibits significant clinical differences.
• Elevated IL-6, while characteristic of CD, is not a reliable sole diagnostic marker due to its presence in other conditions.

Conclusions:

• Accurate differentiation between Castleman disease and TAFRO syndrome remains challenging.
• Novel biomarkers are essential for precise diagnosis and effective management of these rare hematologic disorders.
• Further research is required to elucidate unique pathological and clinical signatures for each condition.